FB2026_03 , released September 17, 2026
Reference Report
Open Close
Reference
Citation
Ahmad, S., Bhatia, K., Kannan, A., Gangwani, L. (2016). Molecular Mechanisms of Neurodegeneration in Spinal Muscular Atrophy.  J. Exp. Neurosci. 10(): 39--49.
FlyBase ID
FBrf0236690
Publication Type
Review
Abstract
Spinal muscular atrophy (SMA) is an autosomal recessive motor neuron disease with a high incidence and is the most common genetic cause of infant mortality. SMA is primarily characterized by degeneration of the spinal motor neurons that leads to skeletal muscle atrophy followed by symmetric limb paralysis, respiratory failure, and death. In humans, mutation of the Survival Motor Neuron 1 (SMN1) gene shifts the load of expression of SMN protein to the SMN2 gene that produces low levels of full-length SMN protein because of alternative splicing, which are sufficient for embryonic development and survival but result in SMA. The molecular mechanisms of the (a) regulation of SMN gene expression and (b) degeneration of motor neurons caused by low levels of SMN are unclear. However, some progress has been made in recent years that have provided new insights into understanding of the cellular and molecular basis of SMA pathogenesis. In this review, we have briefly summarized recent advances toward understanding of the molecular mechanisms of regulation of SMN levels and signaling mechanisms that mediate neurodegeneration in SMA.
PubMed ID
PubMed Central ID
PMC4807884 (PMC) (EuropePMC)
Associated Information
Comments
Associated Files
Other Information
Secondary IDs
    Language of Publication
    English
    Additional Languages of Abstract
    Parent Publication
    Publication Type
    Journal
    Abbreviation
    J. Exp. Neurosci.
    Title
    Journal of experimental neuroscience
    ISBN/ISSN
    1179-0695
    Data From Reference
    Human Disease Models (2)
    Cell Lines (1)